Moreover, within the subgroups of uncircumcised men and Ad5 seropositive men, ELISpot mock responses appeared to have a different effect on the risk of HIV-1 infection in vaccine versus placebo recipients. This evidence concerns the gene PSEN2 and HIV-1 infection.